Background: The contribution of thrombosis to the aetiology of perioperative myocardial infarction (MI) is uncertain. We used optical coherence tomography (OCT) to determine the presence of thrombus and plaque morphology in patients experiencing a perioperative MI and matched patients experiencing a non-operative MI using OCT. Methods: We conducted a single-centre, prospective, cohort study. Thirty patients experiencing a perioperative MI and 30 matched patients experiencing a non-operative MI, without ST elevation, underwent OCT to determine the presence of thrombus and culprit lesion plaque morphology. Angiography and OCT were performed a mean of 1.93(1.09) days and 1.53(0.68) days after the onset of perioperative and non-operative MI, respectively. OCT images were evaluated by an independent core laboratory without knowledge of whether the patient had suffered a perioperative or non-operative MI. Results: We identified thrombus at the culprit lesion in four of 30 patients (13.3%) who experienced a perioperative MI and in 20 of 30 patients (66.7%) who experienced a non-operative MI, P<0.01. The only non-culprit lesion with thrombus was in a perioperative MI patient who also had a culprit lesion thrombus. Perioperative and non-operative MI culprit lesions demonstrated fibroatheroma in 18 patients (60.0%) us 20 patients (66.7%), respectively (P¼0.52) and thin cap fibroatheroma in one patient (3.3%) us five patients (16.7%), respectively (P¼0.11). One perioperative MI patient (3.3%) suffered a cardiac death and no non-operative MI patient died during the 30-day follow-up. Conclusions: Thrombosis was less common in perioperative than non-operative MI, despite similar underlying plaque morphology.
The pathophysiology of myocardial infarction (MI) is classified as type 1 if it results from atherosclerotic plaque rupture, erosion, or dissection with resulting intraluminal thrombosis in a coronary artery, or as type 2 if it results from an imbalance between myocardial oxygen supply and demand. 1 Patients undergoing noncardiac surgery are potentially at risk for both type 1 and type 2 MI. An improved understanding of the mechanism of perioperative MI may help to identify effective prevention and management interventions for this group of patients who have a poor prognosis.
Editor's key points
Surgical patients with coronary artery disease manifest their disease differently to that observed in the nonoperative setting. Intracoronary optical coherence tomography is an imaging technique to detect coronary arterial thrombus. In this study thrombosis occurred less often in postoperative patients with myocardial infarction than in non-operative patients. Non-operative MI culprit lesions had greater stenosis, more angiographic complexity, and patients were more likely to undergo revascularization.
Studies of invasive coronary angiography in patients with perioperative MI suggest that both mechanisms may play a role; 3 4 however, these studies are limited by the low sensitivity of angiography to detect thrombus. 5 Intracoronary optical coherence tomography (OCT) is a highly accurate intravascular imaging technique for the detection of thrombus. 6 7 We conducted the OPtical coherence Tomographic IMaging of thrombUS (OPTIMUS) Study to determine the prevalence of culprit lesion thrombus and plaque morphology in patients experiencing a perioperative MI as compared with a matched cohort of patients experiencing a non-operative MI.
Methods

Study design
The OPTIMUS Study was a single-centre, prospective, cohort study. The study was approved by the Hamilton Integrated Research Ethics Board, and all patients provided written informed consent. Patients were eligible if they were age >18 yr, experienced a perioperative MI (within two weeks after noncardiac surgery) or non-operative MI that fulfilled the Universal Definition of MI and underwent cardiac catheterization within three days of the MI. All patients included in the study had an elevated troponin and fulfilled the universal definition of MI. Troponin concentrations were measured at local institutions using a variety of conventional and highsensitivity troponin I and T assays. No patient recruitment was performed from the surgical wards. Patients were recruited at the catheterization laboratory after the decision to refer for invasive angiography was made on clinical grounds. For each included perioperative MI patient, we evaluated each consecutive patient referred for angiography who had suffered a non-operative MI to identify a patient who was a match based on gender, age ( plus/minus five yr), and the presence or absence of ischaemic electrocardiographic changes. Patients fulfilling any of the following criteria were excluded: ST segment elevation myocardial infarction (STEMI), cardiogenic shock, prior coronary artery bypass surgery, percutaneous coronary intervention with stent implantation in the prior six months, or estimated glomerular filtration rate<35 mL/min.
OCT procedures
After angiography, the interventional cardiologist identified the culprit artery and one additional non-culprit artery for OCT imaging. Section 1 in the Supplementary Appendix describes the criteria for identifying the culprit artery and an additional non-culprit artery for OCT imaging. Section 2 in the Supplementary Appendix describes the angiography and OCT imaging procedures. Reasons for unsuccessful OCT imaging of a coronary artery included severe left main stenosis, severe coronary stenosis that could not be crossed, tortuosity, calcification, chronic total occlusion, absence of a !30% stenotic lesion, or inability to achieve blood clearance on the OCT image.
Angiographic interpretation
All coronary angiograms were evaluated offline at an angiographic core laboratory (Hamilton Health Sciences). The coronary angiograms were analysed with QAngioXA software (Medis, Netherlands), 8 by an interventional cardiologist who was blinded to whether patients had suffered a perioperative or non-operative MI. The SYNTAX score was determined to characterize the extent and complexity of coronary artery disease, 9 and the presence and locations of chronic total occlusions were identified. Left ventricular function and the presence of any wall motion abnormalities were determined. For all culprit and nonculprit lesions, quantitative coronary angiography was performed to assess the baseline TIMI (Thrombolysis in Myocardial Infarction) flow, reference vessel diameter, minimum lumen diameter, and diameter stenosis. TIMI flow is graded on a 4 point scale; 0 indicating no flow beyond the occlusion, 1 indicating contrast penetration beyond the occlusion but incomplete vessel opacification, 2 indicated complete vessel opacification beyond the occlusion but a reduced flow rate, and 3 indicating normal vessel opacification at a normal rate beyond the occlusion. Lesions were characterized as simple or complex (i.e. eccentric with narrow neck, irregular borders, abrupt shoulders, or ulcerations). 10 Evidence of thrombus (i.e.
filling defect seen in multiple projections) was noted.
OCT interpretation
OCT images were evaluated by a core laboratory (Cardiovascular Imaging Core Laboratory, Case Western Reserve University) using proprietary software (Off-line Review Software, version E.0.2; St Jude Medical, MN, USA). 11 The images were analysed without knowledge of whether the patient had suffered a perioperative or non-operative MI. Vessels were deemed non-assessable when residual blood obscured the underlying structures, 11 and non-assessable for the evaluation of plaque rupture, when pre-dilatation was performed before OCT imaging. Qualitative assessment was performed at every 0.2 mm interval to detect the presence of intraluminal thrombus, plaque rupture, fibrous cap, and to evaluate plaque components. The images were evaluated independently by two observers and any discrepancies were resolved by consensus. Section 3 in the Supplementary Appendix describes the OCT imaging outcome definitions (e.g. thrombus, plaque rupture).
Outcome measures
Our primary outcome was the presence of thrombus at the culprit lesion based on OCT imaging. Secondary outcomes based on OCT imaging included: 1) fibroatheroma at the culprit lesion, 2) thin cap fibroatheroma at the culprit lesion, 3) plaque rupture at the culprit lesion, and 4) thrombus at the nonculprit lesion. Study personnel followed patients until 30 days after OCT imaging to determine if patients had a revascularization procedure, an unplanned hospitalization, or death. Revascularization decisions were made by the operators. Fractional flow reserve was not used to guide revascularization.
Statistical analyses
We included a convenience sample of 60 patients (30 per group) who underwent successful OCT imaging of at least one lesion. We also collected data on all perioperative and nonoperative MI patients who had angiography but did not undergo OCT imaging. We calculated proportions for categorical variables and mean and standard deviation (SD) or median and interquartile range (IQR) for continuous variables. Potential differences between perioperative and nonoperative MI based on OCT findings were assessed using a paired Student's t-test for continuous variables, and McNemar's test (two categories) or generalized McNemar test (Stuart-Max well test) for categorical variables. For the comparisons between groups with OCT and groups with angiography only, we used two group Student's t-test for continuous variables and Fisher's exact test for categorical variables. Where significant differences were observed between groups for categorical variables, comparisons were also performed at the level of each category. As a result of unavailable OCT data in some patients, OCT data could not be paired up for all the patients, so the generalized estimating equation (GEE) model analysis was used for the comparison. All analyses were completed in statistical analysis system (SAS) and a P value<0.05 was considered statistically significant.
Results
During part of the OPTIMUS Study recruitment period, routine surveillance of perioperative troponin measurements was conducted at one of the referring hospitals that was participating in the VISION Study at the same time. 12 During this period, 780 patients underwent surgery and 56 were diagnosed with MI of whom six underwent angiography during the same hospitalization. Supplementary Table S1 reports the patient characteristics among patients who suffered an MI who were and were not referred for cardiac catheterization. The only characteristic that differed across these groups was that patients referred for cardiac catheterization had a higher median peak high-sensitivity Troponin T measurement (i.e. 165ng/L; IQR, 86-271) compared with patients who were not referred for cardiac catheterization (i.e. 38 ng/L; IQR, 22-95).
We recruited 91 patients (46 perioperative and 45 nonoperativeMI) of whom 60 (30 perioperative and 30 nonoperative MI) had successful OCT imaging of at least one vessel ( Supplementary Fig. S1 ). In both groups, absence of a lesion !30%, a severe stenosis not crossable with the imaging catheter, and presence of a chronic total occlusion were the most common reasons for not performing OCT imaging in any vessel. Culprit lesion OCT imaging was performed in 29 perioperative and 29 non-operative MI patients. Culprit vessel OCT imaging was not possible in one perioperative MI patient because of the presence of a chronic total occlusion and one non-operative MI patient because of severe left main stenosis. Non-culprit lesion OCT imaging was performed in 22 perioperative and 16 non-operative MI patients. The most common reason for not imaging a non-culprit lesion was the absence of lesions with a !30% stenosis. No adverse complications occurred as a result of OCT imaging. Table 1 reports the baseline clinical characteristics of patients who experienced a perioperative or non-operative MI and underwent OCT imaging. The mean age was 69.6(11.9) for the perioperative MI group and 68.4(11.5) for the non-operative MI group. Ischaemic symptoms were observed in 63.3% of perioperative MI and 100% of non-operative MI patients, P<0.01. Most patients had an ischaemic ECG finding and hypertension, but only a minority of patients had a prior history of myocardial infarction. The mean days to angiography was longer in the perioperative MI group, 1.9(1.1) days us 1.5(0.7) days, P¼0.10. Before angiography, all patients were treated with a therapeutic dose anticoagulant while use of dual antiplatelet therapy was less common in perioperative MI (23 patients, 76.7%) than non-operative MI (29 patients, 96.7%), P¼0.01. Among perioperative MI patients, orthopaedic and vascular surgeries were the most common types of surgery. Table 2 reports the angiographic data of patients who underwent OCT imaging. There was no difference in the mean SYNTAX scores between perioperative and non-operative MI patients. However, TIMI 3 flow at baseline was more common in perioperative (28 patients, 93.3%) than non-operative MI (22 patients, 73.3%), P¼0.03. The culprit lesion was more commonly the right coronary artery, a complex lesion, angiographically thrombotic, and more severely stenosed in nonoperative MI patients. For patients who underwent angiography only (without OCT), baseline characteristics are reported in Supplementary Table S2 and angiographic findings  are reported in Supplementary Table S3 . In comparison to patients with OCT imaging, patients who underwent angiography only had more severe stenoses, lower rates of TIMI 3 flow, and, in the perioperative MI group, a greater proportion of patients with SYNTAX score >32. Plaque rupture was identified in one patient with perioperative MI and five patients with non-operative MI; however, assessment of plaque rupture was limited by the frequent requirement for predilation before imaging. Fig. 1A and B demonstrate a thrombotic and non-thrombotic culprit lesion in patients with perioperative MI, respectively. Supplementary   Fig. S2A and B demonstrate a thrombotic and non-thrombotic culprit lesion in patients with non-operative MI, respectively. Additional case examples of OCT image findings are presented in Supplementary Figs S3 (perioperative MI) and S4 (nonoperative MI). As a result of slightly longer time to angiography in the perioperative MI group, we performed a secondary analysis limited to match pairs in which the difference in time to angiography was less than or equal to one day. In this comparison, the frequency of thrombus was consistent with the overall study results (Supplementary Table S4 ).
Using OCT as the gold standard, angiography had a sensitivity of 33.3% (95% CI 15.6 to 55.3) and specificity of 91.7% (95% CI 77.5, 98.3) for the detection of thrombus (Supplementary  Table S5 ).
For non-culprit lesions undergoing OCT, there were no differences in lesion location, complex lesion morphology, or angiographic thrombus between the patients who had a perioperative or non-operative MI (Supplementary Table S6 ). Diameter stenosis was lower in the perioperative compared with the non-operative MI group (44.8% us 60.5%, respectively) P¼0.01. OCT identified thrombus in one non-culprit lesion in a perioperative MI patient who also had thrombus detected at the culprit lesion site (Supplementary Table S7 ). No plaque ruptures were identified in non-culprit lesions.
Patient level data including symptoms, electrocardiographic changes, troponin values, and OCT findings are provided for all perioperative and non-operative MI patients who underwent OCT in Supplemental Table S8 . Clinical features (symptoms, electrocardiographic changes, troponin concentrations) appeared similar in patients who had a thrombotic us nonthrombotic culprit lesion.
Revascularization was performed in 15 perioperative (50.0%) and 26 non-operative MI patients (86.7%), P¼0.01. The difference was because of more frequent use of percutaneous coronary intervention in the non-operative MI group. One perioperative MI patient (3.3%) suffered a cardiac death; by OCT, this patient had thrombus at the culprit and non-culprit (Table 4) . The outcomes of patients with angiography only are provided in Supplementary Table S9 .
Discussion
Principal findings
Using OCT imaging in patients with perioperative and non-operative MI, we identified thrombus in the culprit lesion in 13.3% of perioperative MI patients and in 66.7% of nonoperative MI patients. The prevalence of culprit lesion fibroatheroma and composition of the culprit lesion were similar between perioperative and non-operative MI patients. Nonoperative MI culprit lesions had a higher diameter stenosis, more angiographic complexity, and were more likely to undergo revascularization.
Strengths and limitations
Strengths of our study include having core laboratories evaluating the angiographic and OCT images blinded to whether patients suffered a perioperative or non-operative MI, and the use of a highly accurate imaging modality for the detection of thrombus (i.e. OCT). Our study has several limitations. We included a convenience sample of patients referred for coronary angiography. Data from one referring centre that also participated in the VISION Study at the same time, identified that patients suffering a perioperative MI who were referred for angiography and included in the OPTIMUS Study had a higher higher median peak highsensitivity Troponin T measurement; however, the absolute difference was only 127 ng L À1 . Perioperative MI patients in this study were more likely to be symptomatic than is typical for perioperative MI in general. The presence of symptoms may have influenced the decision to proceed with invasive angiography by referring clinicians. Data does not, however, suggest that perioperative myocardial infarction with symptoms is higher risk than perioperative myocardial infarction without symptoms. 2 Moreover, in our current study reviewing individual patient characteristics, we did not identify any pattern suggesting that symptomatic patients were more or less likely to have a thrombotic culprit lesion. As a result of the technical requirements of OCT, we could not image all culprit lesions. Most patients excluded from OCT imaging had either no lesion >30% or very extensive disease. Culprit or non-culprit lesions because of a chronic total occlusion could not be imaged with OCT; however, these myocardial infarctions are unlikely as a result of an acute thrombosis and it is unlikely their exclusion would have resulted in under detection of thrombus. Exposure to treatment with anti-platelets and anti-coagulants before catheterization may have reduced or eliminated thrombus in patients after it initially formed. Time to imaging was slightly longer in the perioperative MI group, so any impact of medication before OCT may have been greater in this group.
Almost all STEMIs are associated with thrombus by OCT, 11 and we excluded STEMI patients. Data suggests, however, that a minority of perioperative MIs are a STEMI. 2 Pre-dilation for OCT imaging was required frequently because of occlusive or severe culprit lesions in the non-operative MI patients, so evaluation of plaque rupture was limited. Non-operative MI patients undergoing OCT had less extensive disease than those with angiography alone, suggesting we may have overestimated the role of thrombus in this group.
Our study in relation to other studies
Controversy exists regarding the importance of thrombosis in perioperative MI. In prior autopsy studies, thrombosis was seen in 21 out of 68 patients (30.9%) who died from perioperative MI. 13 14 Almost all patients had obstructive coronary artery disease and the prevalence of left main or severe three vessel coronary artery disease was nearly 50%. Autopsy studies are, however, only able to study patients with fatal events and are likely biased towards inclusion of more severe disease.
Prior angiographic studies demonstrated thrombus in 8% to 26% of perioperative MI cases, 3 4 and our data suggested thrombus on angiography in 7% of perioperative MI patients. Angiographic identification of thrombus requires only the injection of intracoronary contrast for detection; however, the accuracy for thrombus detection is low. 15 For this reason, we utilized OCT to obtain a more reliable estimate of the prevalence of thrombus in patients suffering a perioperative MI. In non-operative MI, we identified that thrombosis was the most common mechanism of myocardial infarction; however, 1/3 rd of patients did not have evidence of a thrombus. Our findings are similar to a prior OCT study that showed thrombus was detected in 65% of non-operative MI patients. 15 We also found a higher frequency of angiographically complex lesions in non-operative MI compared with perioperative MI. These findings are consistent with the previously reported association of complex lesion morphology with thrombotic type 1 myocardial infarction. 10 Prior research has shown that thrombus is present in nearly all cases of non-operative STEMI. In contrast, a significant number of non-operative non-ST elevation MI patients do not have thrombus identified by OCT, suggesting nonthrombotic mechanisms in an appreciable proportion of these patients.
Interpretation
Our data suggests that Type 1 myocardial infarction as a result of thrombus is less common in perioperative MI patients compared with non-operative MI patients. We did, however, observe that the prevalence of fibroatheroma, thin cap fibroatheroma, and plaque composition was similar between perioperative and non-operative MI. Therefore, differences in plaque morphology do not account for the difference in thrombus at the culprit lesion site. Our data did not identify clinical, electrocardiography, or biomarker characteristics that distinguished thrombotic from non-thrombotic events in patients experiencing a perioperative or non-operative MI. These data and the sensitivity of angiography suggests the need for OCT imaging to confidently distinguish between a thrombotic us non-thrombotic MI. Contemporary acute pharmacologic management of non-operative MI involves use of anti-platelet and anticoagulation therapy to target thrombosis. The lower prevalence of thrombus in perioperative MI observed in our study suggests that antiplatelet and anticoagulation strategies may need to be specifically evaluated in the acute perioperative MI context, so that the risk and benefits can be understood. Moreover, in the POISE 2 Trial, pre-operative aspirin did not reduce myocardial infarction and was associated with an increased risk of major bleeding in patients undergoing noncardiac surgery. 16 If most perioperative MIs do not involve thrombosis, attention to avoidance of supply demand mismatch may be a more effective strategy for prevention of these events. For example, a strategy of prolonged perioperative monitoring is being tested to see if cardiovascular events can be reduced after surgery. 17 Angiographically significant coronary artery disease was observed in most perioperative MI patients. These results are similar to our study of pre-operative coronary CT angiography, in which we demonstrated that two-thirds of patient who went on to develop perioperative MI had obstructive disease before surgery. 18 Therefore, most patients with perioperative MI may benefit from long-term secondary prevention therapies to address atherosclerosis such as aspirin, statin, and angiotensinconverting enzyme inhibitor. 2 19 The study also demonstrates that the lesion causing ischaemic events share similar morphological features between perioperative MI and non-operative MI (i.e. similar frequency of lipid rich plaque and fibroatheromas). Therefore, it is conceivable that antithrombotic therapy may prevent recurrent events in patients who experience a perioperative MI. This hypothesis is being tested in the ongoing MANAGE Trial (NCT01661101).
We observed a lower frequency of revascularization in perioperative MI compared with non-operative MI. It is not clear if this is because of unsuitable coronary anatomy, comorbidities, or noncardiac surgical issues. Given the high rate of mortality associated with perioperative MI, the role of revascularization merits further evaluation.
Conclusions
Thrombus was present in one in every eight patients suffering a perioperative MI whereas thrombus was present in two in every three patients suffering a non-operative MI, despite a similar prevalence of culprit lesion fibroatheroma and similar plaque composition. 
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